Lasa Supergenerics Closes Trading Window for Q2 FY27

Lasa Supergenerics Ltd has announced the closure of its trading window for designated employees and their immediate relatives. This closure is in accordance with the company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders. The trading window will remain shut from October 01, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.